Driving a protective allele of the mosquito FREP1 gene to combat malaria.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40702179.
- Also identified by DOI 10.1038/s41586-025-09283-6 and PMC identifier 12443604.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Malaria remains a substantial global health challenge, causing approximately half a million deaths each year<sup>1</sup>. The mosquito fibrinogen-related protein 1 (FREP1) is required for malaria parasites to infect the midgut epithelium<sup>2</sup>. The naturally occurring FREP1<sup>Q</sup> allele has been reported to prevent parasite infection, while supporting essential physiological functions in the mosquito<sup>3</sup>. Here we generate congenic strains of Anopheles stephensi, edited to carry either the parasite-susceptible FREP1<sup>L224</sup> or the putative-refractory FREP1<sup>Q224</sup> alleles. The FREP1<sup>Q224</sup> allele confers robust resistance to infection by both human and rodent malaria parasites, with negligible fitness costs. The protective FREP1<sup>Q224</sup> allele can be efficiently driven into FREP1<sup>L224</sup> mosquito populations using a novel linked allelic-drive system that selectively replaces the L224 codon with the parasite-refractory Q224 allele, thereby rendering populations refractory to parasite infection. This antimalaria drive system provides a novel genetic approach to aid in malaria elimination efforts.
Medical subject headings
- Anopheles
- Fibrinogen
- Gene Drive Technology
- Genes, Insect
- Mosquito Vectors